HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Harmony Biosciences (HRMY) Investors with Substantial Losses to Contact Firm, ...
SAN FRANCISCO, March 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) investors who suffered substantial losses to submit your losses now. Visit: www.hbsslaw.com/investor-fraud/HRMY Contact An Attorney Now: …